Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials | Suppliers

Quintiles - Bringing People and Knowledge Together for a Healthier World White Papers

Quintiles - Bringing People and Knowledge Together for a Healthier World

Transform Clinical Development Through Advances in Risk-Based Monitoring This paper shares the challenges of clinical development along with an approach to trial execution gleaned from years of executing trials with risk-based monitoring (RBM) policies and processes.
View white paper
Integration of Molecular Biomarkers into Clinical Development In the first of this two-part series, strategic drug developers Eric Groves, Jason Hill and Christopher Ung explain why biopharma cannot afford to ignore the growing surge of interest in biomarkers in oncology and discuss their critical role in the modern-day clinical development process.
View white paper
Personalizing Oncology with Genomics Next-generation sequencing will transform oncology clinical trials and treatments for cancer.
View white paper
Biomarkers: Recent Advances in Their Application to the Treatment of Hematologic Malignancies Biomarkers hold promise in the diagnosis, prognosis and therapeutic stratification of hematopoietic malignancies. These heterogeneous diseases - including multiple myeloma, lymphomas and leukemias - are frequently characterized cytogenetically with diagnoses supported by genetic, immunohistochemical and flow cytometric analyses.
View white paper
Integrating Biomarkers in Alzheimer’s Disease Trials Review of compliance with biomarker assessments in Alzheimer’s disease clinical trials.
View white paper
Biomarkers: Key to Better Rheumatoid Arthritis Drug Development and Treatment Rheumatoid arthritis (RA) affects approximately 1% of the world’s population with an ever-increasing burden on health, quality of life and the economy.
View white paper